Clinical Research Blog Archives - Page 3 of 10

Increasing Access to People of African Descent in Pharma: Interview with Peju Oshisanya

Peju Oshisanya joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss diversity and inclusion in clinical trials. An experienced clinical operations specialist and a strong advocate for data diversity, Peju shares her insight into the health sciences industry, evaluates opportunities for improvement, and illuminates the

Posted on 21 Jul 2021
By ArcheMedX Team
In Clinical Research Blog, Interviews

managing clinical trials despite complexity

Successful Clinical Trial Management Now Means Accepting Complexity. Here’s How to Deal with It.

If it shocks you to hear that clinical trials are getting more complex, you haven’t been paying attention. Specifically, we’re collecting more endpoints. We’re performing more procedures. We’re increasing nearly every executional variable, like the number of countries, the number of sites, the number of visits per patient, and the

Posted on 30 Jun 2021
By ArcheMedX Team
In Clinical Research Blog

As the Cost of Clinical Trials Climbs, Here Are 3 Ways to Save

By all accounts, the cost of clinical trials continues to rise. We hear reasons that include increasing protocol complexity, patient recruitment struggles, or regulatory challenges. And we shrug our shoulders. Most of us accept these rising costs and obstacles as a given. But - why? If you could predict the future problems

Posted on 29 Jun 2021
By ArcheMedX Team
In Clinical Research Blog

decentralized clinical trials mean training at scale

A Decentralized Clinical Trial Requires Training at Scale. Here’s What That Means.

The decentralized clinical trial is one of the most talked-about emerging trends in the life sciences industry. These sorts of clinical trials present immense benefits, as we wrote about in a recent blog. If executed well, the decentralized clinical trial design could both reduce resource consumption and accelerate treatments arrival to

Posted on 24 May 2021
By ArcheMedX Team
In Clinical Research Blog

5 Challenges in Working with CROs – and How to Overcome Them

You have a clinical trial starting soon. Are you working with a contract research organization, or at least planning to do so? Probably. In 2020, the ACRP estimated that 70% of clinical trials would involve sponsors working with CROs. And, as a result, 100% of those sponsors will encounter some

Posted on 21 May 2021
By ArcheMedX Team
In Clinical Research Blog

Ken Getz, Kelly Ritch on complexity in clinical trial protocols

How Can We Manage the Increasing Complexity of Clinical Trial Protocols?: Interview with Ken Getz of Tufts Center for the Study of Drug Development

Ken Getz joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss the growing complexity in clinical trial protocols. The Director of the Tufts Center for the Study of Drug Development and a Research Professor at the Tufts University School of Medicine, Ken shares his insights

Posted on 21 May 2021
By ArcheMedX Team
In Clinical Research Blog, Interviews

An Honest Look at How Demanding Oncology Trials Have Become: Interview with Rebecca Setta of Oncosec

Rebecca Setta joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss effective management of sites and teams through arduous clinical trials. Rebecca shares how she’s kept her team motivated and productive in spite of the added burdens imposed by the pandemic, and why she’s excited

Posted on 20 Apr 2021
By ArcheMedX Team
In Clinical Research Blog, Interviews

tackle these clinical trial startup challenges

Got a Clinical Trial Startup Post-COVID? Plan to Tackle 3 Big Challenges

There are still a lot of challenges facing pharmaceuticals, med tech, and biotech companies that seek to begin a clinical trial post-COVID. But the obstacles aren’t stopping them. At time of writing, over 500 companies have a Phase II or Phase III clinical trial startup planned in the next 12

Posted on 30 Mar 2021
By ArcheMedX Team
In Clinical Research Blog

virtual vs. decentralized vs. hybrid clinical trial

Decentralized, virtual, or hybrid clinical trial – what’s the difference?

Increased diversity. Faster enrollment. Reduction in costs. These are just a few of the myriad benefits of the virtual clinical trial touted by CROs and solution providers. But are you ready for a truly virtual clinical trial? If not, is a hybrid clinical trial realistic? And what is a decentralized

Posted on 24 Mar 2021
By ArcheMedX Team
In Clinical Research Blog

What Do You Do When You Don’t Have Enough Clinical Trial Locations: Interview with Krystyna Kowalczyk of Oncobay

Krystyna Kowalczyk joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss innovation and leadership in oncology clinical trials. The founder and CEO of OncoBay Clinical, Krystyna shares her efforts to break the mold when it comes to cancer research, and explores OncoBay's "just in time"

Posted on 18 Mar 2021
By ArcheMedX Team
In Clinical Research Blog, Interviews

Clinical Operations

Commercial Teams

Resources

Medical Education

About Us

Connect with us

Category : Clinical Research Blog

Increasing Access to People of African Descent in Pharma: Interview with Peju Oshisanya

Successful Clinical Trial Management Now Means Accepting Complexity. Here’s How to Deal with It.

As the Cost of Clinical Trials Climbs, Here Are 3 Ways to Save

A Decentralized Clinical Trial Requires Training at Scale. Here’s What That Means.

5 Challenges in Working with CROs – and How to Overcome Them

How Can We Manage the Increasing Complexity of Clinical Trial Protocols?: Interview with Ken Getz of Tufts Center for the Study of Drug Development

An Honest Look at How Demanding Oncology Trials Have Become: Interview with Rebecca Setta of Oncosec

Got a Clinical Trial Startup Post-COVID? Plan to Tackle 3 Big Challenges

Decentralized, virtual, or hybrid clinical trial – what’s the difference?

What Do You Do When You Don’t Have Enough Clinical Trial Locations: Interview with Krystyna Kowalczyk of Oncobay

Social

Recent News

Raising the Bar: Why Quality and Training Will Define Your Success Under ICH E6(R3)

From Outcomes to Insights: 4 Best Practices in Outcomes Storytelling

Contact Us

300 E Main Street, Suite 101 Charlottesville, VA 22902

+1-434-260-1850

Email Us

About Us

Subscribe

Request a Demo